The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two ...

Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen ...

By Andrew Silver SHANGHAI (Reuters) -German healthcare and materials group Merck KGaA has dropped a surcharge on life ...

Merck plans to spend $895 million to expand a De Soto, Kansas, manufacturing facility for its animal health segment, the ...

Gov. Laura Kelly and Merck Animal Health — a veterinary medicine company — announced an $895 million expansion project at the ...

EARNINGS FORECAST: Merck's earnings before interest, taxes, depreciation, amortization and one-off items is forecast to come in at 1.51 billion euros, according to the consensus. The company reported ...

Merck is expanding domestic manufacturing with a $895 million investment in its Kansas factory, one of several major projects ...

Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...

Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, ...

Investing.com -- Citi downgraded both AbbVie (NYSE: ABBV) and Merck (NSE: PROR) to Neutral in separate notes Wednesday, ...

Cyber attacks on companies are no longer a rarity. Volker Buß, CISO at the Merck Group, explains in the CSO interview what is ...

"I must say it's always impressive to come back to China and witness its significant and rapid transformation happening over ...